78
Views
2
CrossRef citations to date
0
Altmetric
Letters

A bifunctional peptide, “peptope”, for pre-targeting antibody 7D8 to systemic amyloid deposits

, , , , , , , , & show all
Pages 22-23 | Received 15 Nov 2016, Accepted 12 Feb 2017, Published online: 22 Apr 2017

References

  • Gertz MA, Landau H, Comenzo RL, Seldin D, Weiss B, Zonder J, Merlini G, et al. First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction. J Clin Oncol 2016;34:1097–103.
  • Langer AL, Miao S, Mapara M, Radhakrishnan J, Maurer MS, Raza S, Mearset JG, et al. Results of phase i study of chimeric fibril-reactive monoclonal antibody 11-1f4 in patients with AL amyloidosis. Blood 2015;126:188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.